Medications
Promacta approval expanded to kids with rare blood disorder
(HealthDay)—U.S. Food and Drug Administration approval of the drug Promacta (eltrombopag) has been expanded to include children one year and older with a rare blood disorder called chronic immune thrombocytopenic purpura ...
Aug 24, 2015
0
5
